Roxane F. Reardon

Roxane Reardon, Global Co-Head of the Firm’s Capital Markets Practice, was quoted in a Bloomberg article titled, “Growing Demand for Convertible Bonds Likely to Survive Rate Cuts.” The article explored the increase in convertible bond issuances in 2023, with Roxane noting that there was a deep education process that went on last year.~~To read the full article, please click here (subscription required).

Oct 1

1 min

Simpson Thacher represented Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC in connection with the registered follow-on offering of 4,887,500 shares of common stock by Aspen Aerogels, Inc. (“Aspen”), which includes the exercise in full of the underwriters’ option to purchase additional shares. The offering raised approximately $97.8 million in gross proceeds.~~Aspen intends to use the net proceeds from the offering for working capital, capital expenditures and general corporate purposes.~~Aspen is an aerogel technology company that designs, develops and manufactures innovative, high-performance aerogel materials used primarily in the energy industrial, sustainable insulation materials and electric vehicle markets.~~The Simpson Thacher team included Roxane Reardon, Dave Azarkh, Traci Biedermann, J. Carr Gamble and Louise Choi (Capital Markets); Michael Mann and Mohanad Salaimi (Tax); Pasco Struhs (Executive Compensation and Employee Benefits); Andrew Pagliughi (FINRA & Blue Sky); Toby Chun and Tim Mulvihill (Environmental); and Chandler Gerard-Reimer (Intellectual Property).

Oct 24

1 min

Simpson Thacher represented J.P. Morgan Securities and A.G.P./Alliance Global Partners as placement agents in connection with a $130 million registered direct offering by Solid Power, Inc. (“Solid Power”) of a combination of Common Stock, Pre-Funded Warrants and Warrants. Solid Power is developing solid-state battery technology to enable the next generation of batteries for the fast-growing EV and other markets. The Simpson Thacher team included Roxane Reardon, Matt Hart and Margaret Selbe (Capital Markets); Jonathan Cantor and Andrew Wasilick (Tax); George M. Gerstein and J. Pasco Struhs (ECEB); Michael R. Isby (Environmental); Ron Ben-Yehuda, Chandler Gerard-Reimer and Tally Smitas (IP); and Jennie Getsin (Blue Sky).

Feb 2

1 min

Simpson Thacher represented the underwriters in connection with a registered public offering by GE HealthCare Technologies Inc. (“GEHC”) of $1 billion aggregate principal amount of 4.800% Senior Notes due 2029. The offering closed on August 14, 2024.~~GEHC is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier.~~The Simpson Thacher team for the transaction included Roxane Reardon, David Azarkh, Jessica Ryan and Leena Sanka (Capital Markets); Vanessa Burrows and Jacob Madden (Healthcare); Andrew Purcell and Paul Jansch (Tax); Pasco Struhs (Executive Compensation and Employee Benefits); Paige Brinton (IP); Abram Ellis, Ryan Stalnaker and Anais Bourbon (Regulatory); and Jennie Getsin (FINRA and Blue Sky).

Aug 14

1 min

The Firm recently represented the underwriters, led by BofA Securities, Inc., Barclays Capital Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, in connection with the public offering by CVS Health Corporation (“CVS Health”) of $5 billion of Senior Notes, consisting of $1 billion of 5.400% Senior Notes due 2029, $1 billion of 5.550% Senior Notes due 2031, $1.25 billion of 5.700% Senior Notes due 2034, $750 million of 6.000% Senior Notes due 2044 and $1 billion of 6.050% Senior Notes due 2054. The offering closed May 9, 2024.~~CVS Health is a leading health solutions company. CVS Health has more than 9,000 retail locations, more than 1,000 walk-in medical clinics, 205 primary care medical clinics, a leading pharmacy benefits manager with approximately 90 million plan members and expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than 800,000 patients per year. CVS Health also serves an estimated more than 36 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan.~~The Simpson Thacher team for the transactions included Roxane Reardon, Matt Hart, Nate Yang and Jerry Du (Capital Markets); Jonathan Cantor and Kris Liu (Tax); Alan Turner and Alexander Rabinowitz (Litigation); Abram Ellis and Christine Tillema (Regulatory); Pasco Struhs (Benefits); Michael R. Isby (Environmental); Paige Brinton (Intellectual Property); Vanessa Burrows and Jacob Madden (Healthcare); and Jennie Getsin (FINRA and Blue Sky).

Oct 5

1 min